➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Medtronic

Last Updated: November 28, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202258

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 202258 describes VICTRELIS, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are three patents protecting this drug. Additional details are available on the VICTRELIS profile page.

The generic ingredient in VICTRELIS is boceprevir. Additional details are available on the boceprevir profile page.
Summary for 202258
Tradename:VICTRELIS
Applicant:Merck Sharp Dohme
Ingredient:boceprevir
Patents:3
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 202258
Generic Entry Date for 202258*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG
Approval Date:May 13, 2011TE:RLD:No
Patent:  Start TrialPatent Expiration:Nov 11, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Mar 17, 2027Product Flag?Substance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Dec 22, 2024Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Baxter
Moodys
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.